Old Web
English
Sign In
Acemap
>
authorDetail
>
M. H. Brampton
M. H. Brampton
Charing Cross Hospital
Medicine
Cancer
Chemotherapy
Temozolomide
Pathology
5
Papers
1210
Citations
0.02
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
1997
Cancer Chemotherapy and Pharmacology
Mark Bower
E. S. Newlands
N M Bleehen
M. Brada
R. J. H. Begent
H. Calvert
I. Colquhoun
P. Lewis
M. H. Brampton
Show All
Source
Cite
Save
Citations (202)
The charing cross hospital experience with temozolomide in patients with gliomas
1996
European Journal of Cancer
E. S. Newlands
S.M. O'Reilly
M.G. Glaser
Mark Bower
H. Evans
Cathryn S. Brock
M. H. Brampton
I. Colquhoun
P. Lewis
J.M. Rice-Edwards
R. D. Illingworth
P.G. Richards
Show All
Source
Cite
Save
Citations (148)
Phase I trial of elactocin.
1996
British Journal of Cancer
E. S. Newlands
G J S Rustin
M. H. Brampton
Show All
Source
Cite
Save
Citations (190)
Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
1993
European Journal of Cancer
S.M. O'Reilly
Edward S. Newlands
M. H. Brampton
M.G. Glaser
J.M. Rice-Edwards
R. D. Illingworth
P.G. Richards
C. Kennard
I. Colquhoun
P. Lewis
Malcolm F. G. Stevens
Show All
Source
Cite
Save
Citations (241)
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).
1992
British Journal of Cancer
Edward S. Newlands
George Blackledge
John A. Slack
Gordon Rustin
David P. Smith
N. S. A. Stuart
Charmaine Paulina Quarterman
Richard Hoffman
Malcolm F. G. Stevens
M. H. Brampton
Show All
Source
Cite
Save
Citations (429)
1